This page lists the SEC filings reported by Palo Alto Investors LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-14 | Palo Alto Investors LP | Karyopharm Therapeutics Inc. | 5,102,193 | 4.4% | EDGAR |
| SC 13G/A | 2024-02-14 | Palo Alto Investors LP | eHealth, Inc. | 2,739,379 | 9.7% | EDGAR |
| SC 13G/A | 2024-02-14 | Palo Alto Investors LP | Revance Therapeutics, Inc. | 5,237,284 | 6.0% | EDGAR |
| SC 13G/A | 2023-04-03 | Palo Alto Investors LP | ALIMERA SCIENCES INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Palo Alto Investors LP | ALIMERA SCIENCES INC | 802,423 | 11.4% | EDGAR |
| SC 13G/A | 2023-02-14 | Palo Alto Investors LP | eHealth, Inc. | 2,484,479 | 9.1% | EDGAR |
| SC 13G/A | 2023-02-14 | Palo Alto Investors LP | Epizyme, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Palo Alto Investors LP | INSMED Inc | 5,871,291 | 4.3% | EDGAR |
| SC 13G/A | 2023-02-14 | Palo Alto Investors LP | Karyopharm Therapeutics Inc. | 5,655,676 | 5.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Palo Alto Investors LP | Revance Therapeutics, Inc. | 5,283,609 | 6.4% | EDGAR |
| SC 13G/A | 2023-02-14 | Palo Alto Investors LP | Vanda Pharmaceuticals Inc. | 1,087,064 | 1.4% | EDGAR |
| SC 13G/A | 2022-02-14 | Palo Alto Investors LP | eHealth, Inc. | 1,615,570 | 6.1% | EDGAR |
| SC 13G/A | 2022-02-14 | Palo Alto Investors LP | Clovis Oncology, Inc. | 3,997,826 | 3.1% | EDGAR |
| SC 13G/A | 2022-02-14 | Palo Alto Investors LP | INSMED Inc | 6,025,706 | 5.1% | EDGAR |
| SC 13G/A | 2022-02-14 | Palo Alto Investors LP | STAAR SURGICAL CO | 1,140,511 | 2.4% | EDGAR |
| SC 13G/A | 2022-02-14 | Palo Alto Investors LP | Revance Therapeutics, Inc. | 4,369,366 | 6.1% | EDGAR |
| SC 13G/A | 2022-02-14 | Palo Alto Investors LP | ALIMERA SCIENCES INC | 802,423 | 11.6% | EDGAR |
| SC 13G/A | 2022-02-14 | Palo Alto Investors LP | Vanda Pharmaceuticals Inc. | 2,834,244 | 5.1% | EDGAR |
| SC 13G/A | 2022-02-14 | Palo Alto Investors LP | Karyopharm Therapeutics Inc. | 5,470,452 | 7.2% | EDGAR |
| SC 13G/A | 2022-02-14 | Palo Alto Investors LP | Epizyme, Inc. | 5,485,213 | 5.3% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.